Who owns Karyopharm Therapeutics Inc note 3.000%10/1?

Tip: Access positions for across all investors

Analyze quarterly positions in Karyopharm Therapeutics Inc note 3.000%10/1 with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Karyopharm Therapeutics Inc note 3.000%10/1 stock

Who bought or sold Karyopharm Therapeutics Inc note 3.000%10/1 this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Affinity Asset Advisors 15M $13M 0% Sep 2025
 View chart
Opaleye Management 6.0M $4.6M 0% Sep 2025
 View chart
Exome Asset Management 2.0M $1.6M 0% Sep 2025
 View chart
BLB^B Advisors 75k $61k 0% Sep 2025
 View chart
Jpmorgan Chase & Co 38k $37k 0% Sep 2025
 View chart